The Holy Grail of medical diagnosis is the identification of specific biomarkers for a predictive diagnosis or the accurate diagnostic confirmation of a pathologic process. Over the past decade, abundant data have confirmed that important epigenetic changes are at the base of many oncogenic processes and that different epigenetic signature might be of clinical utility as biomarkers of cancer.
展开▼